
NDT Pharmaceuticals Inc. NDTP
NDTP
NDT Pharmaceuticals Inc. SLNCF
Silence Therapeutics plc IPHYF
Innate Pharma S.A. BXPHF
Botanix Pharmaceuticals Limited JWCTF
JW (Cayman) Therapeutics Co. Ltd GNFTF
Genfit S.A. BRIBF
Brii Biosciences Limited PRNAF
Alterity Therapeutics Limited SPHDF
Santhera Pharmaceuticals Holding AG BOVNF
BioInvent International AB (publ)
NDT Pharmaceuticals Inc. SLNCF
Silence Therapeutics plc IPHYF
Innate Pharma S.A. BXPHF
Botanix Pharmaceuticals Limited JWCTF
JW (Cayman) Therapeutics Co. Ltd GNFTF
Genfit S.A. BRIBF
Brii Biosciences Limited PRNAF
Alterity Therapeutics Limited SPHDF
Santhera Pharmaceuticals Holding AG BOVNF
BioInvent International AB (publ)
Performance
Periode | NDTP | SLNCF | IPHYF | BXPHF | JWCTF | GNFTF | BRIBF | PRNAF | SPHDF | BOVNF |
---|---|---|---|---|---|---|---|---|---|---|
6M | 1 557.49 % | 68.42 % | 37.93 % | -59.78 % | 179.20 % | 5.08 % | -7.46 % | -32.04 % | -25.38 % | -30.03 % |
YTD | 2 092.26 % | -39.16 % | -31.03 % | -71.09 % | 179.20 % | 5.08 % | 91.79 % | 94.44 % | 30.31 % | -30.03 % |
1Y | 1 376.37 % | -73.77 % | -10.71 % | -56.47 % | 77.37 % | -32.97 % | 91.79 % | 94.44 % | 4.91 % | -30.03 % |
3Y | 23 866.58 % | 21.21 % | -3.38 % | 516.67 % | 18.31 % | 1.64 % | -62.98 % | -12.50 % | -99.13 % | -30.03 % |
5Y | -72.34 % | -67.68 % | -49.87 % | 23.33 % | -84.13 % | -13.08 % | -91.25 % | -84.75 % | 345 774 547.89 % | -28.78 % |
10Y | 16.19 % | -50.77 % | -87.06 % | -53.75 % | -84.13 % | -91.15 % | -91.25 % | -94.81 % | 1 147 196 261 582.24 % | -63.86 % |
From the beginning | -99.77 % | -36.00 % | -87.12 % | -53.75 % | -84.13 % | -87.06 % | -91.25 % | -97.41 % | 27 277 777 677.78 % | -50.17 % |